Belgium· BE-AMP-SAM466213-00
Focuzine 120
A ginkgoblatt product containing ginkgo biloba l., leaf, dry extract, acetone, 60, 35-67_1egb 761, registered in Belgium by Dr. Willmar Schwabe. The same ATC class is registered in 6 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Ginkgoblatt is registered in 6 of 19 countries.
Countries holding a registration under ATC N06DX02 (ginkgoblatt), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 5 of them publish a price we can compare per daily dose
Ginkgoblatt · ATC N06DX02
6 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Ginkgo biloba L., Leaf, Dry Extract, Acetone, 60, 35-67_1EGb 761
- Manufacturer
- Dr. Willmar Schwabe
- Country
- Belgium (BE)
- ATC code
- N06DX02
- ATC class
- Ginkgoblatt
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb4121067
- be_apb4121059
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
22 interactions on record for ginkgoblatt.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ginkgoblatt · interactions on record
22 records
22 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under N06DX02
Ginkgoblatt, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c885abeb-c39f-4cab-a8cc-f66af5b6ebce GET /v1/drugs/c885abeb-c39f-4cab-a8cc-f66af5b6ebce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Focuzine 120",
"name_fr": "Focuzine 120",
"name_nl": "Focuzine 120",
"amp_code": "SAM466213-00",
"strengths": [
"120.0000",
"120.0000",
"68.2500"
],
"pack_count": 12,
"substances": [
"Ginkgo biloba L., Leaf, Dry Extract, Acetone, 60, 35-67_1EGb 761",
"Lactose Monohydrate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Ginkgo Folium",
"authorisation_numbers": [
"BE466213"
]
}See everything about ginkgoblatt.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.